Latest filing published 26 Oct 2026 for AGIOS PHARMACEUTICALS, INC., €264k.
Insider track record
Sarah Gheuens: trading record in brief
This profile gathers the share dealings of Sarah Gheuens in Agios Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 4 August 2026 to 26 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 26 October 2026 came the latest disclosure, a transaction for €264k in Agios Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sarah Gheuens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,866 shares@ US$37.6898CommonSEC144:0001950047-26-010399
- 500 shares@ US$37.520.0008% mcap1.9% of flowCommonSEC144:0001950047-26-010371
- 1,489 shares@ US$37.52940.0025% mcap5.9% of flowCommonSEC144:0001950047-26-010353
- 30,000 shares@ US$30.47610.044% mcap100.0% of flowCommonSEC144:0001950047-26-007592
4 of 4 declarations
